ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Psychiatry

Top Psychiatry Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TSILYA BASS M.D.

Psychiatry

30,629

$4.95M

1127
956 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 25%

$162
Average prescription price

Avg: $143

JANAK MEHTANI M.D.

Psychiatry

10,798

$1.97M

985
189 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$182
Average prescription price

Avg: $143

ARA KADOYAN MD

Psychiatry

17,407

$1.28M

971
650 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $143

SYAM KUNAM MD

Psychiatry

14,308

$1.95M

813
214 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $143

RAMON GARCIA M.D.

Psychiatry

29,122

$5.35M

802
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$184
Average prescription price

Avg: $143

JASWANT KHOKHAR MD

Psychiatry

12,688

$1.63M

748
175 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $143

ELEANOR LAVRETSKY MD

Psychiatry

12,122

$1.32M

724
636 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $143

SAID JACOB M.D.

Psychiatry

10,683

$1.27M

707
270 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$119
Average prescription price

Avg: $143

ASYA KUPISK MD

Psychiatry

12,875

$1.26M

701
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 25%

$98
Average prescription price

Avg: $143

MICHAEL TOLWIN M.D.

Psychiatry

9,795

$1.62M

694
132 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$165
Average prescription price

Avg: $143

DANIEL CHUEH M.D.

Psychiatry

10,112

$1.3M

645
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $143

SAMUEL KUGEL M.D.

Psychiatry

9,772

$1.26M

637
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $143

ARMEEN WEBER M.D.

Psychiatry

12,375

$1.96M

622
70 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$159
Average prescription price

Avg: $143

YAROSLAV KUSHNIR M.D.

Psychiatry

13,404

$1.58M

622
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $143

MEHBOOB MAKHANI M.D.

Psychiatry

8,784

$967K

604
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$110
Average prescription price

Avg: $143

KRISHNA VIJAYASARATHI DO

Psychiatry

9,745

$1.42M

597
83 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$145
Average prescription price

Avg: $143

ALAN MARKIE M.D.

Psychiatry

11,790

$1.63M

591
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $143

SAI CHUNDU MD

Psychiatry

9,094

$988K

590
250 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $143

NAGESWARA GUNTUPALLI M.D.

Psychiatry

6,622

$546K

589
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $143

VICKY BORCK D.O.

Psychiatry

8,683

$852K

583
91 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$98
Average prescription price

Avg: $143

WILLIAM GILLESPIE M.D.

Psychiatry

8,658

$1.28M

553
82 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$148
Average prescription price

Avg: $143

ERIK PASCHALL M.D., M.P.H.

Psychiatry

5,421

$276K

539
423 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $143

JEN HUANG MD

Psychiatry

10,140

$1.04M

528
375 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $143

MUHAMMAD ZIA

Psychiatry

7,512

$777K

518
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $143

HENRY KHIN M.D.

Psychiatry

14,269

$2.35M

513
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$165
Average prescription price

Avg: $143

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank